ExOxEmis, Inc.
Little Rock, AR, US· latest recorded location
ExOxEmis, Inc. is named on 13 US grants and 7 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 13
- Published applications
- 7
- Inventors
- 11
- Granted in 2026 so far
- 0
- Most recent grant
- 19 Jul 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Technology areas
Share of 20 documents
- A61KMedicines and medical preparations18
- A61PTherapeutic uses of medicines17
- C12YEnzymes14
- A61LMethods or apparatus for sterilising materials or objects in general9
- A01NPreservation of bodies of humans or animals or plants or parts thereof7
- C12NMicroorganisms or enzymes6
- Y02ATechnologies for adaptation to climate change3
- A01KAnimal husbandry1
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1
- G01NInvestigating or analysing materials by determining their chemical or physical properties1
Recent patents
- Myeloperoxidase compositions and methods for inhibition of lipopolysaccharides and lipid A19 Jul 2022US 11,389,514 B2
- Bioactive heme-haloperoxidase compositions and methods of their use14 Nov 2017US 9,814,234 B2
- Eosinophil peroxidase compositions and methods of their use10 Oct 2017US 9,782,459 B2
- Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof3 Feb 2015US 8,945,540 B2
- Oxygen activatable formulations for disinfection or sterilization7 Jan 2003US 6,503,507 B1
- Compositions and methods for treating solid cancer30 Oct 2025US 2025/0332226 A1
- Compositions and methods for treating solid cancer14 Dec 2023US 2023/0398190 A1
- Haloperoxidase compositions and uses thereof28 Oct 2021US 2021/0330755 A1
- Myeloperoxidase compositions and methods for inhibition of lipopolysaccharides and lipid a20 Jun 2019US 2019/0183983 A1
- Bioactive heme-haloperoxidase compositions and methods of their use16 Jul 2015US 2015/0196025 A1
Most cited
By later US patents
- Halo peroxidase containing compositions for killing yeast and sporular microorganisms53US 5,389,369 A1995
- Method for killing or inhabiting the growth of sporulating microorganisms with haloperoxidase-containing compositions39US 5,510,104 A1996
- Chemiluminescence assay of in vivo inflammation27US 5,108,899 A1992
- Oxygen activatable formulations for disinfection or sterilization26US 6,503,507 B12003
- Haloperoxidase acid optimum chemiluminescence assay system16US 5,556,758 A1996